Skip to search formSkip to main contentSkip to account menu

guacetisal

Known as: guaiacolic ester, acetylsalicylic acid, 2-(acetyloxy)benzoic acid, 2-methoxyphenyl ester, asa g 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Guacetisal was synthesized from aspirin and guaiacol with an improved manufacture in an yield of 81%. 
1990
1990
Guaiacol acetylsalicylate (GASL) has been shown to possess significant anti-inflammatory, antipyretic and expectorant activities… 
1981
1981
An open clinical study has been carried out on 40 patients of both sexes suffering from prevalently chronic bronchopneumopathy… 
1981
1981
In 40 patients with bronchopulmonary diseases, in prevalence of chronic type, the therapeutic value of a new antiphlogistic… 
1981
1981
A comparative trial conducted on 48 male and 9 female patients suitably selected in terms of indication consisted of a first… 
1981
1981
A single-blind, between-patients trial was run on two randomly formed groups of 15 hospitalised male patients with chronic… 
1981
1981
Controlled clinical research has been carried out on the activity and tolerance of a new active principle, guacetisal (Broncaspin… 
1981
1981
A single-blind, between-patients trial was run to compare the fluidifying, expectorant, antitussive, antipyretic and anti… 
1981
1981
30 patients of senile age suffering from acute and chronic bronchopneumopathies, the latter in acute phase, have been treated… 
1981
1981
An open clinical trial was run on the therapeutic efficacy of a new balsamic-antiinflammatory molecule, guacetisal (presented as…